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Abstract 
A High Performance liquid chromatographic method was developed for the determination of Cephalosporins like 
as: Cefaclor monohydrate, Cefalexine monohydrate, Cefadroxil monohydrate in pharmaceutical dosage forms. 
Isocratic separation was performed on an Enable C18 column (250 mm × 4.6 mm i.d., 5. 0  µm) using 
Triethylamine: Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v/v%) as the mobile phase at a flow rate 
of 1.0 ml/min. The PDA detection wavelength was set at 265nm. The linearity was observed over a 
concentration range of 0 . 1–80 µg/ml for HPLC method (correlation coefficient=0.999). The developed 
methods were validated according to ICH guidelines. The relative standard deviation values for the method 
precision studies were < 2%, and the accuracy was > 99%.  The developed method was used successfully for 
the determination of Cefaclor, Cephalexin, Cefadroxil  in Capsule, Tablet and  dry syrup formulations. 
Keywords: Cefaclor (CA), Cefalexine (CF), Cefadroxil (CX), HPLC. 
 
1. Introduction 
Cefaclor Monohydrate, (CA): (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (Fig. 1) is a second generation cephalosporin antibiotic [1].  
Cephalexine Monohydrate, (CF): (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (Fig. 2) is a first generation cephalosporin antibiotic [1].  
Cefadroxil Monohydrate, (CX): (6R,7R)-7-{[(2R)-2-amino-2-p-hydroxyphenyl]acetamido}-3- methyl-8-oxo-5-
thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (Fig. 3) is a first generation cephalosporin antibiotic 
[1].  
 
 
 
 
(Fig. 1)                                           (Fig. 2)                                              (Fig. 3) 
It is used in the treatment of susceptible infections of the respiratory tract, urinary tract, and skin. 
CA, CF, CX have been found to reduce the corrosion of mild steel in hydrochloric acid solution [2]. According 
to literature surveys, there are different analytical methods reported for the determination of CA, CF, CX. 
It includes UV-Visible spectroscopy [3–12], chemiluminescence [13], near infrared spectroscopy [14], 
potentiometry [15], polarography [16, 17], HPLC [18–26], gel filtration chromatography [27], HPLC [28], 
capillary zone electrophoresis [29], LC-MS [30, 31], and MS [32] methods. But no analytical methods are 
reported for the determination of CEM in dry syrup formulation using the mobile phase Triethylamine: 
Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v/v%) by HPLC (High Performance liquid 
chromatography). So a successful attempt was made to develop and validate a fast, simple, precise, and accurate 
HPLC method for the determination of CA, CF, CX in capsule, tablet and syrup formulation. Specificity and 
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stability parameters for the drug were assessed according to ICH [33]. 
2. Experimental and Chemical Reagents 
Cefaclor monohydrate, Cephalexine monohydrate, Cefadroxil monohydrate (purity of all > 99.8%) was 
obtained as a gift sample from Aurobindo Pharmaceuticals Ltd., India. Methanol (Merck Ltd., Mumbai, 
India) was of HPLC grade. Analytical grade Methanol, Acetonitrile, Triethylamine (Merck GmpH). The Ultra 
Pure water for HPLC was obtained by using the TKA Water Purification System, Germany. The capsule 
formulation containing 500 mg/cap. The dry syrup formulation containing 125 mg/5 ml,  2 5 0  m g / 5 m l ,  
5 0 0  m g / 5 m l .  T h e  t a b l e t  f o r m u l a t i o n  c o n t a i n i n g  1 0 0 0  m g / t a b  of CA, CF, CX was bought 
from the local market. 
2. Instrumention 
Quantitative HPLC was performed on a binary gradient with MERCK-HITACHI Prominence La Chrom 
pumps, with a 20 µl sample injection loop (Auto) and L-2455 PDA detector. The signal was recorded and 
integrated using EZ Chrom Software. An Enable C18, (250 mm × 4.6 mm i.d., particle size 5 µm) was 
used for separation. Chromatographic analysis was carried out at ambient temperature on the column 
using the Triethylamine: Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v/v%) as the mobile phase at 
a flow rate of 1.0 ml/min in isocratic mode. The PDA detection was carried out at 265 nm.  
3. Preparation of Standard and Sample Solution 
Standard stock solutions of CA, CF, CX were prepared by transferring 100 mg of the drug into two separate 100 
ml volumetric flasks having 10 ml of diluents and were ultrasonicated for 5 minutes. Finally the volume 
was made up with suitable diluents, which gave 1000 µg/ml solutions. Powder ( c a p s u l e ,  t a b l e t  a n d  
d r y  s y r u p )  equivalent to 100 mg of CA, CF, CX was accurately measured and transferred into two 
separate 100 ml volumetric flasks, containing 10 ml of diluents and ultrasonicated for 20 minutes; the 
volume was made up and mixed well. Solutions were filtered by a 0.2 µm filter to remove particulate matter, if 
any. The filtered solutions were properly diluted for analysis as already described. The drug present in the 
sample solutions was calculated by using the calibration curves. All the solutions were stored at 2-8 ºC for 
future use. 
4. Method Validation 
4.1 Specificity 
The specificity of the HPLC method was determined by checking the interference of any of the possible 
degradation products and Absorbances produced during study of CA, CF, CX. The study of the drug was 
carried out with Methanol, Triethylamine, Ultra Pure Water for discovering the stability nature of the drug. 
The degraded samples were prepared by taking suitable aliquots of the drug solution, and then undertaking the 
respective stress testing procedures for each solution. After the fixed time period, the stressed test solutions 
were diluted with the mobile phase. For every stress condition, a solution of concentration 50 µg/ml of CA, CF, 
CX was prepared. The specific stress conditions are described as follows. 
4.2 Linearity 
An twelve-point (0.1, 0 . 5, 1.0, 5.0, 10, 20, 30, 40, 50, 60, 70 and 80 µg/ml) calibration curves were prepared 
for the HPLC methods. The peak area for the HPLC was obtained by injecting 20 µl of the drug 
solution into the column. Calibration curves were plotted by taking the peak area curve on the y-axis and the 
concentration (µg /ml) on the x-axis. 
4.3 Precision 
The intraday and interday precision study was carried out to check the reproducibility of the results. A 
concentration of (15, 20, 25) µg/ml and 30 µg/ml of CA, CF, CX (n=3) were analyzed to find out relative 
standard deviation (RSD) for HPLC methods. 
4.5 Accuracy 
To check the accuracy of the proposed method, recovery studies were carried out at 80, 100, and 120% of the 
test concentration. The recovery study was performed three times at each level. The amount of CA, CF, CX 
present in the sample was calculated using the calibration curves. 
4.6 Robustness 
The robustness of the HPLC method was studied by deliberately changing the method parameters like 
flow rate of the mobile phase, detection wavelength, and organic phase composition. A series of system 
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suitability parameters like retention time, theoretical plates, and tailing factor were determined for each 
changed condition according to ICH [33].  
4.7 Limit of Detection and Limit of Quantitation 
The LOD and LOQ were determined separately according to the ICH guidelines. For the HPLC method, 
concentrations providing a signal-to-noise ratio 3:1 and 10:1 were considered as the LOD and LOQ, 
respectively. 
4.8 Results and Discussion 
Optimization of the mobile phase was carried out based on the tailing factor and theoretical plates obtained 
for CA, CF, CX. During the trial runs, the drug was tested with different mobile phase compositions like 
(Triethylamine: Ultra pure water: Acetonitirle: Methanol v/v%) at various compositions (25:25:25:25 
v/v%), (10:20:65:5 v/v%) , and (10:20:68:2 v/v%) and flow rates (0.5, 1.0, and 1.2 ml/min). The mobile 
phase consisting of Triethylamine: Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v/v%) at a flow rate 
of 1.0 ml/min was selected which gave a sharp, symmetric peak for CA, CF, CX. The retention time for CA, CF, 
CX was found to be (3.98, 3.67, 3.16 min) respectively. The run time was 5 min. The tailing factor for CA, CF, 
CX was found to be (1.48, 1.43, 1.26). PDA detection was carried out at 265 nm. The separation was carried 
out at room temperature. Fig.4 (A), (B), (C) Respectively. 
 
 
(A) 
(B) 
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Fig. 4. Chromatograms of CA, CF, CX for Method (A), (B), (C) Respectively 
4.8.1 Specificity 
To evaluate the specificity, a PDA detector was applied to find out the peak purity of the chromatographic 
peaks obtained for the stress-treated drug solution. Peak purity results are indicative for finding out the peak 
homogeneity. The specificity of the HPLC method was determined by checking the interference of any of the 
possible degradation products and Absorbances produced during study of CA, CF, CX. The study of the 
drug was carried out with Methanol, Triethylamine, Ultra Pure Water for discovering the stability nature of the 
drug. The degraded samples were prepared by taking suitable aliquots of the drug solution, and then 
undertaking the respective stress testing procedures for each solution. The UV spectrums (Fig. 5) obtained 
for the blank and placebo show no interference due to the solvent used and presence of the commonly used 
excipients suggesting the specificity of the two methods. 
 
 
Fig. 5. UV Spectrum of Blank Solution (left) and of Placebo Solution (right) 
4.8.2 Linearity 
The calibration curves were found to be linear over a concentration range of 0.1–80 µg/ml for methods 
(correlation coefficient 0.999 for all the methods). The method parameters and regression data are shown in 
Table 1. 
(C) 
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Tab. 1. Analysis of method parameters and regression data 
 
Parameter Cefaclor, 
(CA) 
Cefalexin, 
(CF) 
Cefadroxil, 
(CX) 
Slope 0.199 × 10+6 0.065 × 10+6 0.095 × 10+6 
Intercept 0.205 × 10+6 0.124 × 10+6 0.124 × 10+6 
Correlation Coefficient 0.9995 0.9997 0.9995 
Detection Wavelength, nm 265 
Linear rang, µg/mL 0.1-80 
 
4.8.3 Precision 
The methods were found to be precise as the RSD (%) values for the precision studies were well below 2% 
(n=3). The results are shown in Table 3. 
 
4.8.4 Accuracy 
The accuracy of the developed methods was found out by the standard addition method. High recovery values 
suggest that all three methods are accurate. The results are shown in Table 3. 
4.8.5 Limit of Detection and Limit of Quantitation 
The LOD and LOQ values shown in Table 2 suggest that the developed methods are sensitive to 
determine CEM. 
Tab. 2. Summary of validation parameters 
Parameter Accuracy(recover),% *Precision(RSD),%  LOD, µg/ml LOQ, µg/ml 
Cefaclor (CA) 100.57% 0.29 0.08 0.26 
Cefalexin (CF) 100.57% 0.31 0.06 0.20 
Cefadroxil (CX) 100.74% 0.40 0.09 0.29 
* Average of three determination at each level. 
4.8.6 Robustness 
The HPLC method was found to be robust under deliberate changes in the mobile phase flow rate (±0.1 
mL/min), detection wavelength (±5 nm), and organic phase composition (±2%). The results of system 
suitability for the robustness study are shown in Table 4. For the UV spectroscopic methods, changing the 
slit width shows no significant effect on absorbance, indicating the robustness of the developed methods. 
No significant changes were obtained in the content of CA, CF, CX during the solution stability studies by the 
developed methods. The recoveries for the solution stability by Method was found to be 100.27%, 101.12%, 
and 100.65%, respectively. 
4.8.7 Analysis of Commercial Dry Syrup Formulation 
The developed methods were successfully applied for the determination of CA, CF, CX in the dry syrup 
formulation. The result for the assay of CA, CF, CX is shown in Table 5. The assay results obtained for CA, CF, 
CX in the syrup formulation using the HPLC and UV spectroscopic methods. 
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Tab. 5. Assay of syrup formulation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Average of three determination at each level. 
4.9 Conclusion 
Three novel analytical methods were developed for the determination of (CA, CF, CX). The validation study 
shows the methods are specific, linear, precise, accurate, and sensitive in the proposed working range. The 
methods were found to be fast, simple, accurate, precise, and sensitive. The excipients present in the 
commercial formulation were found to be non-interfering in the assay results. The methods were 
successfully applied for the determination of the drug in dry syrup formulation. Furthermore, the 
developed methods may be applied for the routine analysis of the drug in API, formulations, and dissolution 
medium. 
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